Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis

Journal of Ethnopharmacology

Volumn 130, Issue 1, 2010, Pages 151-157

  Green, Ezekiel ^a,b   Samie, Amidou ^a   Obi, Chikwelu L ^c   Bessong, Pascal O ^a   Ndip, Roland N ^b,d  

^a UNIVERSITY OF VENDA   (South Africa)

^b UNIVERSITY OF FORT HARE   (South Africa)

^c WALTER SISULU UNIVERSITY   (South Africa)

^d UNIVERSITY OF BUEA   (Cameroon)

Author keywords

Drug resistance; Medicinal plants; Mycobacterium tuberculosis; South Africa; Tuberculosis

Indexed keywords

ACETONE; ALCOHOL; ASCLEPIAS FRUTICOSA EXTRACT; BERCHEMIA DISCOLOR EXTRACT; BRIDELIA MICRANTHA EXTRACT; CARICA PAPAYA EXTRACT; GARLIC EXTRACT; HEXANE; METHANOL; PLANT EXTRACT; SCLEROCARYA BIRREA EXTRACT; SECURIDACA LONGEPEDUNCULATA EXTRACT; SOLANUM PANDURIFORME EXTRACT; TERMINALIA SERICEA EXTRACT; UNCLASSIFIED DRUG; WARBUGIA SALUTARIS EXTRACT; XIMENIA CAFFRA EXTRACT;

ARTICLE; BARK; DRUG ISOLATION; ETHNOBOTANY; ETHNOPHARMACOLOGY; MEDICINAL PLANT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLANT LEAF; PLANT ROOT; SOUTH AFRICA; CHEMISTRY; CLASSIFICATION; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; SPECIES DIFFERENCE;

MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PLANT EXTRACTS; PLANTS, MEDICINAL; SOUTH AFRICA; SPECIES SPECIFICITY;

ALLIUM SATIVUM; ASCLEPIAS FRUTICOSA; BERCHEMIA DISCOLOR; BRIDELIA MICRANTHA; CARICA PAPAYA; MYCOBACTERIUM TUBERCULOSIS; SCLEROCARYA BIRREA; SECURIDACA LONGEPEDUNCULATA; SOLANUM PANDURIFORME; TERMINALIA SERICEA; XIMENIA CAFFRA;

EID: 77953808821     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2010.04.033     Document Type: Article

References (69)

1. Andrews J.R., Shah N.S., Gandhi N., Moll T., Friedland G. Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa. Journal of Infectious Diseases 2007, 196:S482-S490.
2. Apak L., Olila D. The in-vitro antibacterial activity of Annona senegalensis, Securidata longepediculata and Steganotaenia araliacea-Ugandan medicinal plants. African Health Sciences 2006, 6:31-35.
3. Appleton C.C., Drewes S.E., Mashimbye M.J., Cunningham A.B. Observations on the molluscicidal properties of (-)-warburganal on the South African Bulinus africanus (Planorbidae). Journal of Medical and Applied Malacology 1992, 4:37-40.
4. Arnold H., Gulumian M. Pharmacopoeia of traditional medicine in Venda. Journal of Ethnopharmacology 1984, 12:35-74.
5. Arnold T.H., Prentice C.A., Hawker L.C., Snyman E.E., Tomalin M., Crouch N.R., Pottas-Bircher C. Medicinal and Magical Plants of Southern Africa: An Annotated Checklist. Strelitzia 13 2002, National Botanical Institute, Pretoria, South Africa, pp. 1-203.
6. Aruoma O.I., Colognato R., Fontana I., Gartlon J., Migliore L., Koike K., Coecke S., Lamy E., Mersch-Sundermann V., Laurenza I., Benzi L., Yoshino F., Kobayashi K., Lee M.C. Molecular effects of fermented papaya preparation on oxidative damage, MAP kinase activation and modulation of the benzo[a]pyrene mediated genotoxicity. Biofactors 2006, 26:147-159.
7. Asres K., Bucar F. Ant-HIV activity against immunodeficiency virus type 1 (HIV-1) and type II (HIV-II) of compounds isolated from the stem bark of Combretum molle. Ethiopian Medical Journal 2005, 43:15-20.
8. Asres K., Mazumder A., Bucar F. Antibacterial and antifungal activities of extracts of Combretum molle. Ethiopian Medical Journal 2006, 44:269-277.
9. Ballell L., Field R.A., Duncan K., Young R.J. New small-molecule synthetic antimycobacterials. Antimicrobial Agents and Chemotherapy 2005, 49:2153-2163.
10. Bashir A.K., Ross M.F., Turner T.D. The alkaloids of Grewia villosa root. Fitoterapia 1987, 58:141-142.
11. Bessong P.O., Rojas L.B., Obi L.C., Tshisikawe P.M., Igunbor E.O. Further screening of Venda medicinal plants for activity against HIV type 1 reverse transcriptase and integrase. African Journal of Biotechnology 2006, 5:526-528.
12. Betti J.L. An ethnobotanical study of medicinal plants among the Baka pygmies in the Dja Biosphere reserve, Cameroon. African Study Monograms 2004, 25:1-27.
13. Bever B.O. Anti-infective activity of chemical components of higher plants. Medicinal Plants of Tropical West Africa 1986, Cambridge University Press, Cambridge, pp. 68-70.
14. Blumberg H.M., Burman W.J., Chaisson R.E., Daley C.L., Etkind S.C., Friedman L.N., Fujiwara P., Grzemska M., Hopewell P.C., Iseman M.D., Jasmer R.M., Koppaka V., Menzies R.I., O'Brien R.J., Reves R.R., Reichman L.B., Simone P.M., Starke J.R., Vernon A.A. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. American Journal of Respiratory and Critical Care Medicine 2003, 167:603-662.
15. Chin Y.-W., Mdee L.K., Mbwambo Z.H., Mi Q., Chai H.-B., Cragg G.M., Swanson S.M., Kinghorn A.D. Prenylated flavonoids from the root bark of Berchemia discolor, a Tanzanian Medicinal Plant. Journal of Natural Products 2006, 69:1649-1652.
16. Chung G.A.C., Aktar Z., Jackson S., Duncan K. High-throughput screen for detecting antimycobacterial agents. Antimicrobial Agents and Chemotherapy 1995, 39:2235-2238.
17. Cragg G.M., Newman D.J., Snader K.M. Natural products in drug discovery and development. Journal of Natural Products 1997, 60:52-60.
18. Eldeen I.M.S., van Staden J. Antimycobacterial activity of some trees used in South African traditional medicine. South African Journal of Botany 2007, 73:248-251.
19. Eldeen I.M.S., van Heerden F.R., van Standen J. Isolation and biological activities of termilignan B and arjunic acid from Terminalia sericea roots. Planta Medica 2008, 74:411-413.
20. Eloff J.N. Which extractant should be used for screening and isolation of antimicrobial components from plants?. Journal of Ethnopharmacology 1998, 60:1-8.
21. Eloff J.N. Antibacterial activity of Marula (Sclerocarya birrea (A. rich) Hochst. Subsp. Caffra (Sond Kokwaro) (Anacardiaceae) bark and leaves. Journal of Ethnopharmacology 2001, 76:305-308.
22. Etkin N.L. Antimalarial plants used by Hausa in Northern Nigeria. Tropical Doctor 1997, 27:12-16.
23. Evans W.C. Trease and Evans' Pharmacognosy 1996, WB Saunders Company Limited, London, pp. 176-177. 14th edition.
24. Fabry W., Okemo P., Ansorg R. Activity of East African medicinal plants against Helicobacter pylori. Chemotherapy 1996, 42:315-317.
25. Farnsworth N.R., Akerele O., Bingel A.S., Soejarto D.D., Guo Z. Medicinal plants in therapy. Bulletin of the World Health Organization 1985, 63:965-981.
26. Ferguson L.R. Role of plant polyphenols in genomic stability. Mutation Research 2001, 475:89-111.
27. Fyhrquist P., Mwasumbi L., Haeggstrom C.A., Vuorela H., Hiltunen R., Vuorela P. Ethnobotanical and antimicrobial investigation on some species of Terminalia and Combretum (Combretaceae) growing in Tanzania. Journal of Ethnopharmacology 2002, 79:169-177.
28. Gandhi N.R., Moll A., Sturm A.W., Pawinski R., Govender T., Lalloo U., Zeller K., Andrews J., Friedland G. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006, 368:1575-1580.
29. Green E., Obi C.L., Nchabeleng M., de Villiers B.E., Sein P.P., Letsoalo T., Hoosen A.A., Bessong P.O., Ndip R.N. Drug-susceptibility pattern of Mycobacterium tuberculosis in Mpumalanga Province, South Africa: possible guiding of retreatment regimen. Journal of Health, Population and Nutrition 2010, 28:7-13.
30. Green E., Obi L.C., Nchabeleng M., de Villiers B.E., Sein P.P., Letsoalo T., Hoosen A.A., Bessong P.O. Molecular characterization of resistant Mycobacterium tuberculosis isolates from Dr George Mukhari Hospital, Pretoria, South Africa. Southern African Journal of Epidemiology and Infection 2008, 23:11-14.
31. Hernandez N.E., Tereschuk M.L., Abdala L.R. Antimicrobial activity of flavonoids in medicinal plants from Tafi del Valle (Tucumán, Argentina). Journal of Ethnopharmacology 2000, 73:317-322.
32. Hutchings A., Scott A.H., Lewis G., Cunningham A.B. Zulu Medicinal Plants-An Inventory 1996, University of Natal Press, Pietermaritzburg, South Africa.
33. Iwalewa E.O., McGaw L.J., Naidoo V., Eloff J.N. Inflammation: the foundation of diseases and disorders. A review of phytomedicines of South African origin used to treat pain and inflammatory conditions. African Journal of Biotechnology 2007, 6:2868-2885.
34. Jadaun G.P.S., Agarwal C., Sharma H., Ahmed Z., Upadhyay P., Faujdar J., Gupta A.K., Das R., Gupta P., Chauhan D.S., Sharma V.D., Katoch V.M. Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtiter assay. Journal of Antimicrobial Chemotherapy 2007, 60:152-155.
35. Kerharo J. Historic and ethnopharmacognostic review on the belief and traditional practices in the treatment of sleeping sickness in West Africa. Bulletin de la Societe de Medecine d'Afrique Noire de Langue Francaise 1974, 19:400.
36. Khan M.R., Ndaalio G., Nkunya M.H., Wevers H., Sawhney A.N. Studies on African medicinal plant. Part 1. Preliminary screening of medicinal plants for antibacterial activity. Planta Medica 1980, 40:91S-97S.
37. Kotze M., Eloff J.N. Extraction of antibacterial compounds from Combretum microphyllum (Combretaceae). South African Journal of Botany 2002, 68:62-67.
38. Lall N., Meyer J.J.M. In vitro inhibition of drug-resistant and drug sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants. Journal of Ethnopharmacology 1999, 66:347-354.
39. Madamombe I.T., Afolayan A.J. Evaluation of antimicrobial activity of extracts from South African Usnea barbata. Pharmaceutical Biology 2003, 41:199-202.
40. Madikane V.E., Bhakta S., Russell A.J., Campbell W.E., Claridge T.D.W., Elisha B.G., Davies S.G., Smith P., Sim E. Inhibition of mycobacterial arylamine N-acetyltransferase contributes to anti-mycobacterial activity of Warburgia salutaris. Bioorganic & Medicinal Chemistry 2007, 15:3579-3586.
41. Masoko P., Picard J., Eloff J.N. The antifungal activity of twenty-four Southern African Combretum species (Combretaceae). South African Journal of Botany 2007, 73:173-183.
42. Mativandlela S.P.N., Meyer J.J.M., Hussein A.A., Houghton P.J., Hamilton C.J., Lall N. Activity against Mycobacterium smegmatis and M. tuberculosis by extracts of South African medicinal plants. Phytotherapy Research 2008, 22:841-845.
43. Mashimbye M.J., Maumela M.C., Drewes S.E. A drimane sesquiterpenoid lactone from Warburgia salutaris. Phytochemistry 1999, 51:435-438.
44. McGaw L.J., Jäger A.K., van Staden J. Isolation of antibacterial fatty acids from Schotia brachypetala. Fitoterapia 2002, 73:431-433.
45. Mehdipour S., Yasa N., Dehghan G., Khorasani R., Mohammadirad A., Rahimi R., Abdollahi M. Antioxidant potentials of Iranian Carica papaya juice in vitro and in vivo are comparable to a tocopherol. Phytotherapy Research 2006, 20:591-594.
46. Molina-Salinas G.M., Ramos-Guerra M.C., Vargas-Villarreal J., Mata-Cárdenas B.D., Becerril-Montes P., Said-Fernández S. Bactericidal activity of organic extracts from Flourensia cernua DC against strains of Mycobacterium tuberculosis. Archives of Medical Research 2006, 37:45-49.
47. More G., Tshikalangea T.E., Lall N., Botha F., Meyer J.J.M. Antimicrobial activity of medicinal plants against oral microorganisms. Journal of Ethnopharmacology 2008, 119:473-477.
48. Msonthi J.D., Magombo D. Medicinal herbs in Malawi and their uses. Hamdard 1983, 26:94-100.
49. Nakanishi K., Kubo I. Studies on warburganal, muzigadial and related compounds. Israel Journal of Chemistry 1977, 16:28-31.
50. Ndip R.N., Tarkang A.E.M., Mbullah S.M., Luma H.N., Malongue A., Ndip L.M., Nyongbela K., Wirmum C., Efange S.M.N. In vitro anti-Helicobacter pylori activity of selected medicinal plants from North West Cameroon. Journal of Ethnopharmacology 2007, 114:452-457.
51. Ngemenya M.N., Mbah J.A., Tane P., Titanji V.P.K. Antibacterial effects of some Cameroonian medicinal plants against common pathogenic bacteria. African Journal of Traditional Complimentary and Alternative Medicine 2006, 3:84-93.
52. Okunade A.L., Elvin-Lewis M.P.F., Lewis W.H. Natural antimycobacterial metabolites: current status. Phytochemistry 2004, 65:1017-1032.
53. Onunkwo G.C., Akah P.A., Udeala O.K. Studies on Bridelia ferruginea leaves. Stability and hypoglycemic actions of the leaf extract tablets. Phytotherapy Research 1996, 10:418-420.
54. Pegel K.H., Rogers C.B. Constituents of Bridelia micrantha. Phytochemistry 1968, 7:655-656.
55. Pereira M., Tripathy S., Indamdar V., Ramesh K., Bhavsar M., Date A., Iyyer R., Acchammachary A., Mehendale S., Risbud A. Drug resistance pattern of Mycobacterium tuberculosis in seropositive and seronegative HIV-TB patients in Pune, India. Indian Journal for Medical Research 2005, 121:235-239.
56. Rabe T., van Staden J. Isolation of an antibacterial sesquiterpenoid from Warburgia salutaris. Journal of Ethnopharmacology 2000, 73:171-174.
57. Samie A., Obi C.L., Bessong P.O., Namrita L. Activity profiles of fourteen selected medicinal plants from Rural Venda communities in South Africa against fifteen clinical bacterial species. African Journal of Biotechnology 2005, 4:1443-1451.
58. Schinor E.C., Salvador M.J., Ito I.Y., Dias D.A. Evaluation of the antimicrobial activity of crude extracts and isolated constituents from Chresta scapigera. Brazilian Journal of Microbiology 2007, 38:145-149.
59. Steenkamp V. Traditional herbal remedies used by South African women for gynaecological complaints. Journal of Ethnopharmacology 2003, 86:97-108.
60. Thring T.S.A., Weitz F.M. Medicinal plant use in the Bredasdorp/Elim region of the southern Overberg in the Western Cape Province of South Africa. Journal of Ethnopharmacology 2006, 103:261-275.
61. Thring T.S.A., Springfield E.P., Weitz F.M. Antimicrobial activities of four plant species from the Southern Overberg region of South Africa. African Journal of Biotechnology 2007, 6:1779-1784.
62. Venter F., Venter J.A. Making the Most of Indigenous Trees 1996, Briza Publications, Pretoria.
63. Victor T.C., Streicher E.M., Kewley C., et al. Spread of an emerging Mycobacterium tuberculosis drug-resistant strain in the Western Cape of South Africa. International Journal of Tuberculosis and Lung Diseases 2007, 11:195-201.
64. Watt C., Breyer-Brandwyk M.G. The Medicinal and Poisonous Plants of Southern and Eastern Africa 1962, E&S. Livingstone Ltd., Edinburgh and London, p. 449.
65. World Health Organization, 2000. Global tuberculosis control. WHO report 2000, Geneva, WHO, 2000 (document WHO/CDS/TB/2000.275, ) (accessed 4 February 2010). http://www.who.int/gtb/publications/globrep00/index.html.
66. World Health Organization Expect committee on specification for Pharmaceutical preparation, 1992. Quality Assurance of Pharmaceuticals. Thirty-second report. World Health Organization, Geneva. pp. 44-76.
67. World Health Organization, 2007a. Global Tuberculosis Control: Surveillance, Planning, Financing: WHO Report. WHO/HTM/TB/2007.376. WHO, Geneva.
68. World Health Organization WHO, 2007b. Towards Universal Access: Scaling Up Priority HIV/AIDS Interventions in the Health Sector; Progress Report, April 2007. WHO, Geneva.
69. World Health Organization Global Tuberculosis Control: Surveillance, Planning and Financing 2008, WHO, Geneva. http://www.sahealthinfo.org/noveldrug/novelpamphlet.htm.